Literature DB >> 7155918

Diet, bowel function, fecal characteristics, and large bowel cancer in Denmark and Finland.

O M Jensen, R MacLennan, J Wahrendorf.   

Abstract

Some 30 randomly selected men, aged 50-59 years, were investigated in each of 4 areas--Copenhagen, Them (rural Denmark), Helsinki, and Parikkala (rural Finland)--to determine the relationship of diet, gut transit time, fecal bulk, fecal bacteriology, bile acid concentration, and urinary volatile phenol production to large bowel cancer risk. Average daily fat intake was found to be high in all 4 areas, and no differences emerged between areas. Saturated fatty acid consumption was higher in low-incidence areas than in high-incidence areas. Intakes of nonstarch polysaccharides (the main component of dietary fiber), carbohydrate, and protein (mainly milk) were higher in the low-incidence area of Parikkala than in the high-incidence area of Copenhagen. The fecal bile acid concentration was higher in the high-incidence area than in the low-incidence area, with the other 2 areas having intermediate values. Fecal bulk showed an inverse association with colorectal cancer incidence. No differences were observed with regard to fecal bacteriology or mutagenic activity of the foods. These results indicate that a population can have a low risk of colorectal cancer despite a high intake of dietary fat, protein, and meat. Dietary carbohydrate and fiber may be considered protective. One mechanism limiting colorectal cancer risk could be the increase in fecal bulk resulting from such intakes, since increased fecal bulk dilutes the increased colonic bile acid concentrations of subjects on high-fat diets.

Entities:  

Mesh:

Year:  1982        PMID: 7155918     DOI: 10.1080/01635588209513733

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  26 in total

1.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

Review 2.  Diet, the gut microbiome, and epigenetics.

Authors:  Meredith A J Hullar; Benjamin C Fu
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 3.  Fiber and cancer.

Authors:  D Kritchevsky
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.

Authors:  Betsy C Wertheim; Jeffrey W Smith; Changming Fang; David S Alberts; Peter Lance; Patricia A Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-04

5.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

6.  Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.

Authors:  Patricia A Thompson; Betsy C Wertheim; Denise J Roe; Erin L Ashbeck; Elizabeth T Jacobs; Peter Lance; María Elena Martínez; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

7.  Fat intake and cancer of the gastrointestinal tract and prostate.

Authors:  R MacLennan
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

8.  Influence of age, intestinal transit time, and dietary composition on fecal bile acid profiles in healthy subjects.

Authors:  F M Nagengast; S D van der Werf; H L Lamers; M P Hectors; W C Buys; J M van Tongeren
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

Review 9.  Nutrition and colorectal cancer.

Authors:  J D Potter
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

10.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.